Status: current, Defined. Date: 30-Sep 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4453851000168118 | Vyndaqel (tafamidis meglumine 20 mg) capsule, 30 capsules (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4453861000168116 | Vyndaqel 20 mg capsule, 30 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Vyndaqel 20 mg capsule, 30 | Is a | tafamidis meglumine 20 mg capsule, 30 | true | Inferred relationship | Some | ||
| Vyndaqel 20 mg capsule, 30 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Vyndaqel 20 mg capsule, 30 | has TP | Vyndaqel | true | Inferred relationship | Some | ||
| Vyndaqel 20 mg capsule, 30 | has TPUU | Vyndaqel 20 mg capsule | true | Inferred relationship | Some | 287443938 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Vyndaqel 20 mg capsule, 30, blister pack | Is a | True | Vyndaqel 20 mg capsule, 30 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR